Shire (SHP)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4366.50p Today's change: +0.98%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4366.50p 5 day change: +0.61%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4366.50p 6 month change: +26.16%

Contact details

Address: 22 Grenville Street, St Helier, Jersey
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: www.shire.com

Company information

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

Shares in London-listed pharmaceuticals giant Shire got a shot in the arm this morning after it emerged Japan's [...]

19 April 2018
Views
694

London-listed rare disease specialist Shire is facing criticism over executive pay from leading shareholder advisory [...]

18 April 2018
Views
320

Shares in Ireland-based biotech Shire have zoomed up two per cent this morning after it revealed it will sell [...]

16 April 2018
Shares
5
Views
254

Healthcare is big business, and pharmaceuticals have done well by investors. But is there any life left in this [...]

10 April 2018
Shares
3
Views
706

Shares in Japanese pharmaceuticals giant Takeda dropped today after the company was forced to reveal it was mulling [...]

29 March 2018
Views
364

Facebook founder Mark Zuckerbeg had another difficult week after he was criticised for refusing to appear before [...]

29 March 2018
Views
395

Shares in pharmaceuticals giant Shire have soared as much as 25 per cent this morning after Japan's Takeda said [...]

28 March 2018
Shares
1
Views
606

Daniel Loeb's hedge fund Third Point has continued to make strong gains throughout November, according to a performance [...]

1 December 2017
Shares
1
Views
525

Shares in pharmaceutical giant Shire fell in afternoon trading, despite it naming a new chief financial officer.  [...]

20 November 2017
Views
867

The share prices of some the UK's best-known companies appeared to fall as much as 99 per cent today, after the [...]

20 November 2017
Shares
10
Views
3,606

Among the products manufactured by Shire, the London-listed drugs group, are several treatments for Attention [...]

18 October 2017
Views
1,595

Shares in pharmaceuticals firm Shire edged up today after the company revealed the UK had validated marketing [...]

15 August 2017
Shares
3
Views
661

Shares in FTSE-100 listed Shire nudged up over two per cent this afternoon after the pharma group reported a [...]

2 May 2017
Views
390

Some of Britain’s biggest companies are set to face a fresh bout of shareholder rebellions over high levels [...]

23 April 2017
Shares
4
Views
1,179

Credit Suisse looks set to come under more pressure over executive pay this year despite the bank making efforts [...]

18 April 2017
Shares
11
Views
294

Content tagged with "Shire"